Dutasteride likely reduces Bone Mineral Density
    Research/Science 3/30/2026

    New to Dutasteride? There is a guide in the encyclopedia. Read the guide β†’
    At a glance
    In this educational post, the primary subjects mentioned are
    πŸ’Š Dutasteride (oral) 0.5 mg weekly 2 years
    the tone is 😐 neutral.

    Other terms

    Dutasteride may reduce bone mineral density, but there's no increased risk of osteoporosis or fractures compared to finasteride. Users suggest resistance training to counter potential bone effects.
    View this post in the Community β†’

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injuryβ€”a randomized, double-blind, and placebo-controlled pilot study

      December 2024 in “Frontiers in Neurology”
      In this pilot randomized clinical trial, TRT combined with finasteride increased lean mass, muscle size, and bone mineral density without prostate enlargement in men with spinal cord injury, suggesting potential benefits for body composition and musculoskeletal health.

      research Transmasculine Hormone Therapy

      6 citations , April 2019 in “Endocrinology and Metabolism Clinics of North America”
      This study observed that testosterone therapy in transgender men enhances both physical and mental health, is safe in the short and middle term with proper follow-up, and highlights the need for endocrinologists to provide gender-affirming care despite its limited presence in medical education.

      research Steroid Hormones

      3 citations , January 2016 in “Elsevier eBooks”
      This article discusses the various roles of steroids in vertebrate organ systems and notes several glucocorticoids that were among the Top 200 Drugs by sales in the 2010s, but it reports no new clinical findings.

      research Advances in male hormone substitution therapy

      23 citations , August 2005 in “Expert opinion on pharmacotherapy”
      This review examines the benefits and potential risks of androgen replacement therapy for male hypogonadism but reports no new clinical results; the authors highlight the need for careful risk assessment, especially in older men.

      research Endocrinology of Transgender Medicine

      166 citations , October 2018 in “Endocrine Reviews”
      This review discusses the effects of hormonal treatments on the physical and mental health of transgender individuals, reporting significant reductions in mental health issues following treatment, but calls for more research on long-term and nonbinary outcomes.